Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: David Winkler who wrote (1753)	2/18/1999 9:20:00 AM
From: Jetter	Read Replies (1) \| Respond to of 2135

David, I think your reasoning would hold if BMY was still in the picture. ENMD's loss of BMY is a devestating loss of confidence for most serious biotech investors. In comparrison, ENMD looks heavily overvalued compared to similar Biotech in the AS/ES field.

To: David Winkler who wrote (1753)	2/18/1999 10:27:00 AM
From: Jetter	Read Replies (2) \| Respond to of 2135

Looks like ENMD could not hold any gains this morning. Here comes the next round of selling. Sorry David, but it still continues to look like this one is falling like a rock... MM's could only sell so much on market orders this am, now its time to continue the trend. Looks like you buying opportunity is here...